Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01480440 · ClinicalTrials.gov registry record
Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
A clinical trial of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.
- Active
- Registry status
- 200
- Enrollment target
- 5
- Study locations
NCT01480440: Active study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.
NCT01480440 is a study of Rheumatoid Arthritis and Osteoarthritis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 200 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01480440, a study of Rheumatoid Arthritis and Osteoarthritis, is active but no longer recruiting, sponsored by Zimmer Biomet.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.
Primary Outcome
Based on removal or intended removal of the device and determined using the Kaplan-Meier method.
Conditions Studied
Interventions
- DEVICE Trabecular Metal Reverse Shoulder System
Study Locations (5)
California
- University of California, San Francisco - San Francisco
Kentucky
- Norton Orthopaedic & Sports Medicine - Louisville
New Jersey
- The Rothman Institute - Egg Harbor
Pennsylvania
- The Rothman Institute - Philadelphia
Lancashire
- Royal Blackburn Hospital - Blackburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-01 |
| Est. Completion | 2026-12 |
What the registry record for NCT01480440 still lists
NCT01480440 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower).
The record links to 8 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Trabecular Metal Reverse Shoulder System is the first listed.
NCT01480440 lists 5 locations in 5 states (California, Kentucky, New Jersey).
Frequently Asked Questions
What is clinical trial NCT01480440 about?
NCT01480440 is a clinical study titled "Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System". The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.
What is the current status of trial NCT01480440?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2011-01. Estimated completion is 2026-12.
What conditions does trial NCT01480440 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Avascular Necrosis, Post Traumatic Arthritis, Ununited Humeral Head Fracture.
What interventions are being tested in trial NCT01480440?
The interventions under investigation include: Trabecular Metal Reverse Shoulder System (DEVICE).
Who is sponsoring clinical trial NCT01480440?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01480440 being conducted?
This trial has 5 study locations across California, Kentucky, New Jersey, Pennsylvania, Lancashire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01480440's enrollment target sits among peer trials
200 84th of 197 higher than 110 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia